CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Edaravone

依达拉奉 杂质对照品Edaravone Impurities

47 个杂质条目47 impurity entries

本页汇总 依达拉奉 的 47 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 47 impurity reference standards of Edaravone. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 依达拉奉(Edaravone)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDevelopment and Validation of a Stability-Indicating RP-HPLC Method for Edaravone Quantification
    Molecules (Basel, Switzerland) · 2025 · O'Neill R et al.  ·  PMID 40649379  ·  DOI
  2. 杂质研究Impurity studiesStress degradation of edaravone: Separation, isolation and characterization of major degradation products
    Biomedical chromatography : BMC · 2018 · Baghel M, Rajput SJ  ·  PMID 29171029  ·  DOI
  3. 杂质研究Impurity studiesEdaravone prevents iNOS expression by inhibiting its promoter transactivation and mRNA stability in cytokine-stimulated hepatocytes
    Nitric oxide : biology and chemistry · 2008 · Yoshida H et al.  ·  PMID 18078833  ·  DOI
  4. 分析方法Analytical MethodsDevelopment and application of a LC-MS/MS assay for the simultaneous quantification of edaravone and taurine in beagle plasma
    Journal of separation science · 2013 · Yu YY et al.  ·  PMID 24133013  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisSynthesis of the metabolites of a free radical scavenger edaravone (MCI-186, Radicut)
    Redox report : communications in free radical research · 2003 · Watanabe K et al.  ·  PMID 12935313  ·  DOI

依达拉奉 —— 原料药与杂质对照品Edaravone — drug substance & impurities

共 48 个条目(含原料药本体)48 items incl. the drug substance
Edaravone structure
原料药 APIAPI
依达拉奉Edaravone
Edaravone
CAS No.89-25-8
Chemical FormulaC10H10N2O
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 1 structure
1
依达拉奉杂质1Edaravone Impurity 1
Edaravone Impurity 1
CAS No.177415-76-8
Chemical FormulaC20H18N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 2 structure
2
依达拉奉杂质2Edaravone Impurity 2
Edaravone Impurity 2
CAS No.1357477-99-6
Chemical FormulaC13H14N2O6S
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 3 Hydrochloride structure
3
依达拉奉杂质3盐酸盐Edaravone Impurity 3 Hydrochloride
Edaravone Impurity 3 Hydrochloride
CAS No.59-88-1
Chemical FormulaC6H8N2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 4 structure
4
依达拉奉杂质4Edaravone Impurity 4
Edaravone Impurity 4
CAS No.1323485-71-7
Chemical FormulaC13H16N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity N4 structure
N4
依达拉奉杂质N4Edaravone Impurity N4
Edaravone Impurity N4
CAS No.14575-62-3
Chemical FormulaC10H10N2O
Purity>95%现货In stock
10mg25mg50mg100mg
Edaravone Impurity 6 structure
6
依达拉奉杂质6Edaravone Impurity 6
Edaravone Impurity 6
CAS No.1242471-40-4
Chemical FormulaC13H16N2O5S
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 6 Sodium Salt structure
6
依达拉奉杂质6 钠盐Edaravone Impurity 6 Sodium Salt
Edaravone Impurity 6 Sodium Salt
CAS No.1322767-62-3
Chemical FormulaC13H15N2O5S-·Na+
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 7 structure
7
依达拉奉杂质7Edaravone Impurity 7
Edaravone Impurity 7
CAS No.68195-63-1
Chemical FormulaC30H26N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 8 Sodium Salt structure
8
依达拉奉杂质8 钠盐Edaravone Impurity 8 Sodium Salt
Edaravone Impurity 8 Sodium Salt
CAS No.663618-36-8
Chemical FormulaC10H9N2O4S-·Na+
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 8 structure
8
依达拉奉杂质8Edaravone Impurity 8
Edaravone Impurity 8
CAS No.76407-98-2
Chemical FormulaC10H10N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 9 structure
9
依达拉奉杂质9Edaravone Impurity 9
Edaravone Impurity 9
CAS No.2832241-44-6
Chemical FormulaC10H12N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 11 structure
11
依达拉奉杂质11Edaravone Impurity 11
Edaravone Impurity 11
CAS No.710307-89-4
Chemical FormulaC10H12N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 12 structure
12
依达拉奉杂质12Edaravone Impurity 12
Edaravone Impurity 12
CAS No.19735-89-8
Chemical FormulaC10H10N2O
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 13 structure
13
依达拉奉杂质13Edaravone Impurity 13
Edaravone Impurity 13
CAS No.124009-63-8
Chemical FormulaC30H26N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 14 structure
14
依达拉奉杂质14Edaravone Impurity 14
Edaravone Impurity 14
CAS No.1016-41-7
Chemical FormulaC12H14N2O
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 16 structure
16
依达拉奉杂质16Edaravone Impurity 16
Edaravone Impurity 16
CAS No.92-43-3
Chemical FormulaC9H10N2O
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 20 structure
20
依达拉奉杂质20Edaravone Impurity 20
Edaravone Impurity 20
CAS No.5393-61-3
Chemical FormulaC10H10N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 22 (Mixture of E/Z-isomers) structure
22
依达拉奉杂质22 (混合E/Z构型)Edaravone Impurity 22 (Mixture of E/Z-isomers)
Edaravone Impurity 22 (Mixture of E/Z-isomers)
CAS No.6078-46-2
Chemical FormulaC12H16N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 24 structure
24
依达拉奉杂质24Edaravone Impurity 24
Edaravone Impurity 24
CAS No.300543-31-1
Chemical FormulaC12H14N2O
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 25 structure
25
依达拉奉杂质25Edaravone Impurity 25
Edaravone Impurity 25
CAS No.29214-62-8
Chemical FormulaC8H12O4
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 27 structure
27
依达拉奉杂质27Edaravone Impurity 27
Edaravone Impurity 27
CAS No.607-67-0
Chemical FormulaC10H9NO
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 30 structure
30
依达拉奉杂质30Edaravone Impurity 30
Edaravone Impurity 30
CAS No.69560-52-7
Chemical FormulaC14H14N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 31 structure
31
依达拉奉杂质31Edaravone Impurity 31
Edaravone Impurity 31
CAS No.27349-35-5
Chemical FormulaC11H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 33 structure
33
依达拉奉杂质33Edaravone Impurity 33
Edaravone Impurity 33
CAS No.7477-67-0
Chemical FormulaC20H18N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 34 structure
34
依达拉奉杂质34Edaravone Impurity 34
Edaravone Impurity 34
CAS No.852539-02-7
Chemical FormulaC13H14N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 39 structure
39
依达拉奉杂质39Edaravone Impurity 39
Edaravone Impurity 39
CAS No.288-13-1
Chemical FormulaC3H4N2
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 40 structure
40
依达拉奉杂质40Edaravone Impurity 40
Edaravone Impurity 40
CAS No.2762440-12-8
Chemical FormulaC13H16N2O5S
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 41 structure
41
依达拉奉杂质41Edaravone Impurity 41
Edaravone Impurity 41
CAS No.2762440-11-7
Chemical FormulaC13H16N2O5S
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 42 structure
42
依达拉奉杂质42Edaravone Impurity 42
Edaravone Impurity 42
CAS No.56248-10-3
Chemical FormulaC10H8N2O
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 43 structure
43
依达拉奉杂质43Edaravone Impurity 43
Edaravone Impurity 43
CAS No.33421-60-2
Chemical FormulaC20H18N4O
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 44 structure
44
依达拉奉杂质44Edaravone Impurity 44
Edaravone Impurity 44
CAS No.153952-07-9
Chemical FormulaC20H18N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 45 structure
45
依达拉奉杂质45Edaravone Impurity 45
Edaravone Impurity 45
CAS No.2061958-41-4
Chemical FormulaC12H16N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 46 structure
46
依达拉奉杂质46Edaravone Impurity 46
Edaravone Impurity 46
CAS No.1086213-77-5
Chemical FormulaC10H10N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 49 structure
49
依达拉奉杂质49Edaravone Impurity 49
Edaravone Impurity 49
CAS No.216655-20-8
Chemical FormulaC22H22N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 50 structure
50
依达拉奉杂质50Edaravone Impurity 50
Edaravone Impurity 50
CAS No.311813-91-9
Chemical FormulaC15H11N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 52 structure
52
依达拉奉杂质52Edaravone Impurity 52
Edaravone Impurity 52
CAS No.2055116-47-5
Chemical FormulaC22H22N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 56 structure
56
依达拉奉杂质56Edaravone Impurity 56
Edaravone Impurity 56
CAS No.91198-39-9
Chemical FormulaC10H8Cl2N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 57 structure
57
依达拉奉杂质57Edaravone Impurity 57
Edaravone Impurity 57
CAS No.103-02-6
Chemical FormulaC9H12N2
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 58 structure
58
依达拉奉杂质58Edaravone Impurity 58
Edaravone Impurity 58
CAS No.92753-34-9
Chemical FormulaC11H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 59 structure
59
依达拉奉杂质59Edaravone Impurity 59
Edaravone Impurity 59
CAS No.876-92-6
Chemical FormulaC9H8N2O
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 60 (Mixture of E/Z-isomers) structure
60
依达拉奉杂质60 (混合E/Z构型)Edaravone Impurity 60 (Mixture of E/Z-isomers)
Edaravone Impurity 60 (Mixture of E/Z-isomers)
CAS No.27301-70-8
Chemical FormulaC10H10N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 69 structure
69
依达拉奉杂质69Edaravone Impurity 69
Edaravone Impurity 69
CAS No.140861-96-7
Chemical FormulaC10H12N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 72 structure
72
依达拉奉杂质72Edaravone Impurity 72
Edaravone Impurity 72
CAS No.61466-03-3
Chemical FormulaC21H18N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 74 structure
74
依达拉奉杂质74Edaravone Impurity 74
Edaravone Impurity 74
CAS No.881-05-0
Chemical FormulaC10H8N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 76 structure
76
依达拉奉杂质76Edaravone Impurity 76
Edaravone Impurity 76
CAS No.78576-13-3
Chemical FormulaC10H10N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 78 structure
78
依达拉奉杂质78Edaravone Impurity 78
Edaravone Impurity 78
CAS No.37409-69-1
Chemical FormulaC10H10N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Edaravone Impurity 82 structure
82
依达拉奉杂质82Edaravone Impurity 82
Edaravone Impurity 82
CAS No.98395-58-5
Chemical FormulaC21H20N4O2
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

依达拉奉 —— 研究文献与合成路线Edaravone — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 依达拉奉 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Edaravone. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Stress degradation of edaravone: Separation, isolation and characterization of major degradation products
    Baghel M, Rajput SJ · Biomedical chromatography : BMC · 2018 · 被引 3cited 3
  2. Edaravone suppresses degradation of type II collagen
    Huang C, Liao G, Han J, et al. · Biochemical and biophysical research communications · 2016 · 被引 3cited 3

合成与制备工艺专利Synthesis & process patents

  1. Edaravone compound synthesized by new method
    MINGGUI YANG · 公开号 CN101830852CN101830852 · 2010
  2. STABLE WATER-SOLUBLE PREPARATION CONTAINING EDARAVONE
    YANAGIMOTO TAKESHI, HASEGAWA CHISA · 公开号 JP2009143902JP2009143902 · 2009
  3. Edaravone lyophilized preparation and preparation technique thereof
    JIAN HE, XIAOQIANG LI, SHENGJUAN HUANG, ZHENG JIANG, et al. · 公开号 CN101288650CN101288650 · 2008

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

依达拉奉 杂质谱研究要点Edaravone — impurity profiling notes

下面这些是拿到 依达拉奉 的 48 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 48 impurity entries for Edaravone, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances